首页> 美国卫生研究院文献>Endoscopic Ultrasound >Evidence-based recommendations for establishing and implementing an EUS program: Recommendations for sustainable success and improved clinical outcomes across the continuum of care
【2h】

Evidence-based recommendations for establishing and implementing an EUS program: Recommendations for sustainable success and improved clinical outcomes across the continuum of care

机译:建立和实施EUS计划的循证医学建议:贯穿整个护理过程的可持续成功和改善临床结果的建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

“Since its introduction, in the 1980s, endoscopic ultrasonography has been shown to be a safe and effective diagnostic and therapeutic tool for the evaluation of hepatobiliary and gastrointestinal conditions.”[ ] Interventional endoscopy, which includes ERCP and EUS, can provide both diagnostic and therapeutic benefits to many types of patients. EUS has been adopted into numerous interventional techniques and strategies that promise to improve diagnosis and management of gastrointestinal (GI) cancers. EUS has matured beyond its conventional role in locoregional staging of GI cancers and should be a standard of care recognized as a well-established procedure. EUS can assist gastroenterology providers with the detection of intraductal extension of adenomas and the detection and staging of pancreatic cancer and can serve as an adjunct to traditional imaging studies, such as computed tomography (CT) and magnetic resonance imaging (MRI). EUS has been proven to be clinically superior to CT, MRI, and transabdominal ultrasound for tumor staging in multiple clinical studies. It is also a tremendous clinical asset for staging GI cancers such as gastric, ampullary, rectal, cholangiocarcinoma, and esophageal and other cancers such as lung cancer. EUS is well documented in assessing for chronic pancreatitis and evaluating thick gastric folds and pancreatic lesions, masses, stones, and strictures. The addition of an EUS program to an existing core and/ or interventional gastroenterology program can be advantageous for healthcare facilities, interventional endoscopists, patients, and communities. In an effort to drive quality and value in endoscopy, PENTAX Medical (Canada) held an advisory board in September 2018 during the Forum for Canadian endoscopic UltraSound (FOCUS) in Montreal, Canada. The goal of this panel discussion was to develop a framework to assist physicians in establishing an EUS program in their hospital. In attendance were physicians with a wide range of experience, who either had well-established programs with high patient volumes or were aiming to implement a new program at their facility. The considerations for discussion were personal experiences and challenges with EUS programs, considerations before starting new EUS programs, building a business case to start new EUS programs, and EUS training program requirements.
机译:“自1980年代问世以来,内窥镜超声检查已被证明是评估肝胆和胃肠道疾病的安全有效的诊断和治疗工具。” []包括ERCP和EUS在内的介入内窥镜检查可提供诊断和治疗。对许多类型患者的治疗益处。 EUS已被许多干预技术和策略所采用,有望改善胃肠道(GI)癌症的诊断和管理。 EUS在胃肠道癌的局部分期中已经超越了其常规作用,已经成为公认的公认标准的治疗标准。 EUS可以协助肠胃病学提供者检测腺瘤的导管内扩展以及胰腺癌的检测和分期,并且可以作为传统成像研究(例如计算机断层扫描(CT)和磁共振成像(MRI))的补充。在多项临床研究中,EUS已被证明在肿瘤分期方面在临床上优于CT,MRI和经腹超声。它也是分期胃肠癌的巨大临床资产,例如胃癌,壶腹癌,直肠癌,胆管癌,食道癌和其他癌症,例如肺癌。 EUS在评估慢性胰腺炎和评估胃厚褶皱以及胰腺病变,肿块,结石和狭窄方面有充分的文献记载。在现有的核心和/或介入胃肠病学计划中增加EUS计划对于医疗机构,介入内镜医师,患者和社区而言可能是有利的。为了提高内窥镜检查的质量和价值,PENTAX Medical(加拿大)于2018年9月在加拿大蒙特利尔举行的加拿大内窥镜超声论坛(FOCUS)期间设立了一个咨询委员会。这次小组讨论的目的是建立一个框架,以协助医师在其医院建立EUS计划。与会的是具有广泛经验的医生,他们要么拥有完善的计划,而且患者人数众多,要么打算在自己的设施中实施新计划。讨论的考虑因素是EUS计划的个人经验和挑战,启动新的EUS计划之前的考虑因素,建立启动新的EUS计划的业务案例以及EUS培训计划的要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号